Stock MANNKIND CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. MannKind Corporation Nasdaq

Equities

US56400P2011

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for MannKind Corporation
Mar. 26 MannKind CFO Binder to Retire in April, Names New CFO MT
Mar. 26 MannKind Corporation Announces Chief Financial Officer Changes, Effective April 22, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oppenheimer Adjusts MannKind Price Target to $5.50 From $6.50, Maintains Outperform Rating
MT
Wedbush Initiates MannKind at Outperform With $10 PT; Says Orphan Lung Pipeline Presents Potential for Real Future Value-Creation, Optionality
MT
HC Wainwright Adjusts Price Target on MannKind to $7.50 From $7, Keeps Buy Rating
MT
HC Wainwright Adjusts Price Target on MannKind to $7 From $6, Keeps Buy Rating
MT
SVB Securities Adjusts Price Target on MannKind to $6 From $5, Maintains Outperform Rating
MT
HC Wainwright Trims MannKind's Price Target to $6 From $6.50, Maintains Buy Rating
MT
MANNKIND : Initiated at Sector Perform by RBC, Price Target Set at $5/Share
MT
MANNKIND : SVB Leerink Adjusts Price Target on MannKind to $5 From $3, Maintains Outperform Rating
MT
MANNKIND : BTIG Research Adjusts MannKind PT to $8 From $4, Maintains Buy Rating
MT
MANNKIND : Oppenheimer Adjusts MannKind PT to $7 From $3, Maintains Outperform Rating
MT
MANNKIND : Oppenheimer Adjusts MannKind PT to $3 From $2.50, Maintains Outperform Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MNKD Stock
  4. Stock
  5. News MannKind Corporation
  6. Analyst Reco.